• Company Type For Profit
  • Contact Email info@caprotec.com
  • Phone Number +1 781-222-6000

caprotec bioanalytics has developed a ground-breaking, proprietary technology to reduce the complexity of protein mixtures and samples in a targeted and directed manner.

caprotec's Capture Compound Mass Spectrometry (CCMS) Technology is based on multifunctional small molecules (Capture Compoundsâ„¢) that are used to target, capture, and

isolate proteins based on their functionality. For many applications, CCMS is clearly superior to shotgun approaches - thus addressing an unmet need in the proteomics community.

Lists Featuring This Company

Acquired Massachusetts Companies
4,025 Number of Organizations • $72.2B Total Funding Amount • 7,279 Number of Investors
Biotechnology Companies that Exited
7,139 Number of Organizations • $724.2B Total Funding Amount • 19,853 Number of Investors
Health Care Companies that Exited (Top 10K)
9,988 Number of Organizations • $791.6B Total Funding Amount • 22,476 Number of Investors
Closed Northeastern US Companies (Top 10K)
9,746 Number of Organizations • $88.3B Total Funding Amount • 12,803 Number of Investors

Frequently Asked Questions

Where is Caprotec Bioanalytics's headquarters? Caprotec Bioanalytics is located in Wilmington, Massachusetts, United States.Who invested in Caprotec Bioanalytics? Caprotec Bioanalytics has 5 investors including KfW and Creathor Ventures.How much funding has Caprotec Bioanalytics raised to date? Caprotec Bioanalytics has raised .When was the last funding round for Caprotec Bioanalytics? Caprotec Bioanalytics closed its last funding round on May 9, 2011 from a Series B round.Who are Caprotec Bioanalytics's competitors? Alternatives and possible competitors to Caprotec Bioanalytics may include MerckCelator Pharmaceuticals, and SteepRock.